Company Puma Biotechnology Inc OTC Bulletin Board
Equities
PBYI
US74587V1070
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.73 USD | 0.00% | 0.00% | 0.00% |
05-17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
05-02 | Transcript : Puma Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Care Products
100.0
%
| 228 | 100.0 % | 236 | 100.0 % | +3.34% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 228 | 100.0 % | 236 | 100.0 % | +3.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 18-11-04 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-02-28 |
Investor Relations Contact | - | - | |
Jeffrey Ludwig
PRN | Corporate Officer/Principal | 58 | 20-02-29 |
Douglas Hunt
LAW | General Counsel | 59 | 17-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 18-02-22 |
Jay Moyes
BRD | Director/Board Member | 70 | 12-04-26 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Director/Board Member | 63 | 22-07-28 | |
Director/Board Member | 60 | 15-08-10 | |
Troy Wilson
BRD | Director/Board Member | 55 | 13-10-17 |
Allison Dorval
BRD | Director/Board Member | 48 | 21-07-14 |
Brian Stuglik
BRD | Director/Board Member | 64 | 20-07-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 48,238,850 | 40,808,140 ( 84.60 %) | 0 | 84.60 % |
Company contact information
Puma Biotechnology, Inc.
10880 Wilshire Boulevard Suite 2150
90024-4101, Los Angeles
+
http://www.pumabiotechnology.comSector
1st Jan change | Capi. | |
---|---|---|
+39.40% | 50.93B | |
-0.22% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.95% | 26.02B | |
-22.29% | 18.9B | |
+8.81% | 13.21B | |
+24.56% | 12.17B | |
+29.74% | 12.16B |
- Stock Market
- Equities
- PBYI Stock
- PBYI Stock
- Company Puma Biotechnology Inc